The Elsevier Office of Continuing Medical Education and Excerpta Medica appreciate your opinions; they help assist us in evaluation of the effectiveness of this activity and identifying your ongoing educational needs. Please complete this entire evaluation form; you must complete this form to receive acknowledgement for completing this activity.

*
*
*
*
*
*
*
*
*
Please use the scale: 1=Poor, 2=Fair, 3=Good, 4=Very good, 5=Excellent
12345
Describe the typical clinical picture of SMA and its natural history, and differentiate between SMA types on the basis of neurological examination and gene profiling
Select and appropriately use standardized assessment tools and tests to monitor for clinical change and disease progression
Understand the modes of action and clinical profiles of emerging therapies and their possible roles in the modern treatment paradigm
Develop a comprehensive, multidisciplinary care plan and know how to modify the therapeutic approach as SMA progresses
*
Please use the scale: 1=Very rarely, 2=Rarely, 3=Neutral/NA, 4=Often, 5=Very often, N/A=Not applicable for me
12345N/A
Use deletion testing and gene sequencing to confirm the diagnosis of SMA in your practice.
Use standardized assessment tools and tests to monitor for clinical change and disease progression in patients with SMA.
Utilize the multidisciplinary team approach to improve patient adherence.
*
Please use the scale: 1=Very rarely, 2=Rarely, 3=Neutral/NA, 4=Often, 5=Very often, N/A=Not applicable for me
12345N/A
Use deletion testing and gene sequencing to confirm the diagnosis of SMA in your practice.
Use standardized assessment tools and tests to monitor for clinical change and disease progression in patients with SMA.
Utilize the multidisciplinary team approach to improve patient adherence.
*
Strongly disagreeDisagreeNeutralAgreeStrongly agree
Overall, this activity met my learning needs
The information presented was without promotional or commercial bias
Was scientifically rigorous and evidence based
Provided appropriate and effective opportunities for active learning (e.g., discussion, Q&A)
The quality of the educational process was satisfactory and appropriate
The information provided with regard to faculty financial relationships met my needs for disclosure
The speakers were knowledgeable and presented the information clearly
The format of the discussion was relevant and enhanced my knowledge of the subject
*
Please use the scale: 1=Poor, 2=Fair, 3=Good, 4=Very Good, 5=Excellent
12345
Richard Finkel (Program Chair)
Basil Darras
Amy Pasternak
Perry Shieh
*
*

Attestation to time spent on activity:

The Elsevier Office of Continuing Medical Education designates this live activity for a maxiumum of 1.5 AMA PRA Category 1 CreditsTM.

*